comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 10:05:18 - browse：4

Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth has made it easy to schedule a virtual visit and get a script, sometimes within minutes, with prescriptions shipped to your doorstep.

Now, Big Pharma is ready to get in on the action.

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Using LillyDirect, patients click into a pipeline for their condition — obesity, diabetes, or migraine — and are routed to telehealth sites that can prescribe them one of Lilly’s drugs if they’re eligible. An integration with online pharmacy Truepill will deliver the meds.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： What is microchimerism and how does it affect maternal health?

leisure time

WSS

Medicare must police algorithms in Medicare Advantage, Dems say

Roivant's CEO is a star, but biotech's black hole persists

Prime Medicine says its gene editing passes test in monkeys

Travis Kelce and the trap of celebrity vaccine endorsements

Is there really a nursing shortage in the U.S.?

Live blog: Hearing on CRISPR

entertainment

comprehensive

Wikipedia

Hollywood unions extend contract negotiations for actors

Life sciences investors close nearly $6 billion in new funds

Sports medicine is finally prioritizing gender equality

Prime Medicine says its gene editing passes test in monkeys

Virginia high school admissions case could be legal follow

UnitedHealth, Optum discontinue NaviHealth name

The cancer drug shortage isn’t new — and neither are the solutions

Lung cancer screening guidelines updated for cigarette smokers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth, Optum discontinue NaviHealth name

knowledge

Health tech investors get more selective as pandemic boom fades

STAT Summit: Ending the crisis of Black deaths in the U.S.

Explaining an after

STAT Summit: Meghan O’Rourke on making chronic illness visible

Inari Medical to buy amputation prevention company LimFlow

STAT Summit: How researchers deal with rejection

explore

leisure time

focus

entertainment